Skip to content
10-K

Annual Report

ARTELO BIOSCIENCES, INC. ARTL

0001640334-26-000368

← back to feed
Filed
Feb 24, 2026 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2025 · Feb 20, 2026 2.12M sh
Shares Diluted FY 2025 · Dec 31, 2025 1.03M sh
Shares Diluted restated FY 2025 · Dec 31, 2024 537K sh
Operating Cash Flow FY 2025 · Dec 31, 2025 −$8.52M
Operating Cash Flow FY 2025 · Dec 31, 2024 −$8.35M
Cash And Equivalents FY 2025 · Dec 31, 2025 $600K
Stockholders Equity FY 2025 · Dec 31, 2025 −$1.27M
Stockholders Equity FY 2025 · Dec 31, 2024 $2.86M
Stockholders Equity FY 2025 · Dec 31, 2023 $11.75M
Current Liabilities FY 2025 · Dec 31, 2025 $4.04M
Current Liabilities FY 2025 · Dec 31, 2024 $1.77M
Total Liabilities FY 2025 · Dec 31, 2025 $4.07M
Total Liabilities FY 2025 · Dec 31, 2024 $1.84M
Current Assets FY 2025 · Dec 31, 2025 $695K
Current Assets FY 2025 · Dec 31, 2024 $2.56M
Total Assets FY 2025 · Dec 31, 2025 $2.8M
Total Assets FY 2025 · Dec 31, 2024 $4.7M
Eps Diluted FY 2025 · Dec 31, 2025 −$12.52
Eps Diluted restated FY 2025 · Dec 31, 2024 −$18.30
Sga Expense FY 2025 · Dec 31, 2025 $5.98M
Sga Expense FY 2025 · Dec 31, 2024 $4.12M
Rd Expense FY 2025 · Dec 31, 2025 $5.42M
Rd Expense FY 2025 · Dec 31, 2024 $5.99M
Net Income FY 2025 · Dec 31, 2025 −$12.88M
Net Income FY 2025 · Dec 31, 2024 −$9.83M
Operating Income FY 2025 · Dec 31, 2025 −$11.4M
Operating Income FY 2025 · Dec 31, 2024 −$10.11M